Abbott Laboratories Long-Term Investments 2010-2024 | ABT

Abbott Laboratories long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Abbott Laboratories long-term investments for the quarter ending September 30, 2024 were $0.912B, a 15.74% increase year-over-year.
  • Abbott Laboratories long-term investments for 2023 were $0.799B, a 4.31% increase from 2022.
  • Abbott Laboratories long-term investments for 2022 were $0.766B, a 6.13% decline from 2021.
  • Abbott Laboratories long-term investments for 2021 were $0.816B, a 0.61% decline from 2020.
Abbott Laboratories Annual Long-Term Investments
(Millions of US $)
2023 $799
2022 $766
2021 $816
2020 $821
2019 $883
2018 $897
2017 $883
2016 $2,947
2015 $4,041
2014 $229
2013 $119
2012 $274
2011 $378
2010 $302
2009 $1,133
Abbott Laboratories Quarterly Long-Term Investments
(Millions of US $)
2024-09-30 $912
2024-06-30 $877
2024-03-31 $818
2023-12-31 $799
2023-09-30 $788
2023-06-30 $799
2023-03-31 $776
2022-12-31 $766
2022-09-30 $764
2022-06-30 $734
2022-03-31 $763
2021-12-31 $816
2021-09-30 $812
2021-06-30 $805
2021-03-31 $832
2020-12-31 $821
2020-09-30 $803
2020-06-30 $776
2020-03-31 $790
2019-12-31 $883
2019-09-30 $874
2019-06-30 $851
2019-03-31 $867
2018-12-31 $897
2018-09-30 $971
2018-06-30 $940
2018-03-31 $913
2017-12-31 $883
2017-09-30 $1,386
2017-06-30 $1,545
2017-03-31 $1,756
2016-12-31 $2,947
2016-09-30 $2,997
2016-06-30 $3,339
2016-03-31 $3,552
2015-12-31 $4,041
2015-09-30 $3,055
2015-06-30 $243
2015-03-31 $244
2014-12-31 $229
2014-09-30 $221
2014-06-30 $130
2014-03-31 $122
2013-12-31 $119
2013-09-30 $143
2013-06-30 $154
2013-03-31 $146
2012-12-31 $274
2012-09-30 $380
2012-06-30 $390
2012-03-31 $375
2011-12-31 $378
2011-09-30 $393
2011-06-30 $452
2011-03-31 $390
2010-12-31 $302
2010-09-30 $255
2010-06-30 $251
2010-03-31 $1,120
2009-12-31 $1,133
2009-09-30 $1,111
2009-06-30 $1,052
2009-03-31 $1,054
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $204.059B $40.109B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Stryker (SYK) United States $139.868B 31.52
Boston Scientific (BSX) United States $124.863B 35.90
Medtronic (MDT) Ireland $114.537B 17.04
EssilorLuxottica (ESLOY) France $110.799B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.365B 0.00
Haleon (HLN) United Kingdom $44.180B 28.71
GE HealthCare Technologies (GEHC) United States $39.743B 20.61
ResMed (RMD) United States $35.761B 29.39
Terumo (TRUMY) Japan $28.532B 40.29
Koninklijke Philips (PHG) Netherlands $25.454B 19.48
Zimmer Biomet Holdings (ZBH) United States $21.582B 13.74
Baxter (BAX) United States $18.264B 12.39
Insulet (PODD) United States $16.648B 70.04
Smith & Nephew SNATS (SNN) United Kingdom $11.052B 0.00
Bio-Rad Laboratories (BIO) United States $10.282B 35.10
BellRing Brands (BRBR) United States $8.726B 36.90
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $8.016B 19.24
ICU Medical (ICUI) United States $4.201B 40.09
TG Therapeutics (TGTX) United States $3.771B 0.00
Haemonetics (HAE) United States $3.763B 18.61
Envista Holdings (NVST) United States $3.662B 27.28
Prestige Consumer Healthcare (PBH) United States $3.657B 18.22
Perrigo (PRGO) Ireland $3.466B 10.95
Neogen (NEOG) United States $3.127B 36.08
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.988B 18.00
QuidelOrtho (QDEL) United States $2.628B 16.56
Agios Pharmaceuticals (AGIO) United States $2.557B 0.00
Green Thumb Industries (GTBIF) United States $2.260B 38.14
LeMaitre Vascular (LMAT) United States $2.165B 52.65
Curaleaf Holdings (CURLF) Canada $2.023B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.960B 0.00
Warby Parker (WRBY) United States $1.769B 0.00
AtriCure (ATRC) United States $1.641B 0.00
InMode (INMD) Israel $1.460B 8.78
AdaptHealth (AHCO) United States $1.365B 9.85
Verano Holdings (VRNOF) United States $1.231B 0.00
BioLife Solutions (BLFS) United States $1.179B 0.00
Evolus (EOLS) United States $1.036B 0.00
Owens & Minor (OMI) United States $0.925B 7.23
National Vision Holdings (EYE) United States $0.915B 29.08
Phibro Animal Health (PAHC) United States $0.906B 18.80
CeriBell (CBLL) United States $0.893B 0.00
Capricor Therapeutics (CAPR) United States $0.844B 0.00
Cresco Labs (CRLBF) United States $0.747B 0.00
VAREX IMAGING (VREX) United States $0.542B 16.36
Surmodics (SRDX) United States $0.536B 113.85
Quanterix (QTRX) United States $0.532B 0.00
Canopy Growth (CGC) Canada $0.515B 0.00
Valneva SE (VALN) France $0.475B 0.00
ZimVie (ZIMV) United States $0.398B 33.56
Viemed Healthcare (VMD) United States $0.331B 35.54
Aurora Cannabis (ACB) Canada $0.328B 0.00
OraSure Technologies (OSUR) United States $0.315B 8.12
TerrAscend (TSNDF) Canada $0.309B 0.00
Jin Medical (ZJYL) China $0.308B 0.00
Sanara MedTech (SMTI) United States $0.293B 0.00
Cerus (CERS) United States $0.290B 0.00
Biote (BTMD) United States $0.280B 12.93
Ayr Wellness (AYRWF) United States $0.279B 0.00
Zynex (ZYXI) United States $0.255B 53.33
Omeros (OMER) United States $0.246B 0.00
High Tide (HITI) Canada $0.234B 97.00
MacroGenics (MGNX) United States $0.232B 0.00
Utah Medical Products (UTMD) United States $0.225B 15.14
Organigram Holdings (OGI) Canada $0.195B 0.00
Brainsway (BWAY) Israel $0.172B 206.40
FitLife Brands (FTLF) United States $0.145B 19.54
Rockwell Medical (RMTI) United States $0.121B 0.00
TriSalus Life Sciences (TLSI) United States $0.117B 0.00
Quipt Home Medical (QIPT) United States $0.113B 0.00
Veru (VERU) United States $0.107B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 23.90
Fonar (FONR) United States $0.092B 9.51
Jushi Holdings (JUSHF) United States $0.092B 0.00
Cellectar Biosciences (CLRB) United States $0.082B 0.00
Zevia PBC (ZVIA) United States $0.079B 0.00
InterCure (INCR) Israel $0.079B 0.00
Modular Medical (MODD) United States $0.073B 0.00
Safety Shot (SHOT) United States $0.065B 0.00
Sanuwave Health (SNWVD) United States $0.064B 1.63
MariMed (MRMD) United States $0.062B 0.00
Cytosorbents (CTSO) United States $0.047B 0.00
Allurion Technologies (ALUR) United States $0.045B 0.00
Exagen (XGN) United States $0.043B 0.00
Apyx Medical (APYX) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Nephros (NEPH) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
GlucoTrack (GCTK) United States $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 17.87
SNDL (SNDL) Canada $0.000B 0.00